- Home
- TYGO vs ORMP Comparison
TYGO vs ORMP Comparison
Compare TYGO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- ORMP
- Stock Information
- Founded
- TYGO 2007
- ORMP 2002
- Country
- TYGO United States
- ORMP United States
- Employees
- TYGO N/A
- ORMP N/A
- Industry
- TYGO Semiconductors
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- TYGO Technology
- ORMP Health Care
- Exchange
- TYGO Nasdaq
- ORMP Nasdaq
- Market Cap
- TYGO 116.0M
- ORMP 104.6M
- IPO Year
- TYGO N/A
- ORMP N/A
- Fundamental
- Price
- TYGO $2.23
- ORMP $2.20
- Analyst Decision
- TYGO Strong Buy
- ORMP
- Analyst Count
- TYGO 1
- ORMP 0
- Target Price
- TYGO $6.00
- ORMP N/A
- AVG Volume (30 Days)
- TYGO 608.3K
- ORMP 127.3K
- Earning Date
- TYGO 10-28-2025
- ORMP 11-07-2025
- Dividend Yield
- TYGO N/A
- ORMP N/A
- EPS Growth
- TYGO N/A
- ORMP N/A
- EPS
- TYGO N/A
- ORMP N/A
- Revenue
- TYGO $90,781,000.00
- ORMP $2,000,000.00
- Revenue This Year
- TYGO $95.15
- ORMP N/A
- Revenue Next Year
- TYGO $21.54
- ORMP N/A
- P/E Ratio
- TYGO N/A
- ORMP N/A
- Revenue Growth
- TYGO 97.41
- ORMP N/A
- 52 Week Low
- TYGO $0.58
- ORMP $1.82
- 52 Week High
- TYGO $2.95
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- TYGO 47.83
- ORMP 38.06
- Support Level
- TYGO $1.97
- ORMP $2.30
- Resistance Level
- TYGO $2.37
- ORMP $2.40
- Average True Range (ATR)
- TYGO 0.21
- ORMP 0.11
- MACD
- TYGO -0.05
- ORMP -0.01
- Stochastic Oscillator
- TYGO 36.29
- ORMP 0.00
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.